• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

先天性心脏病经导管介入治疗风险调整方法(CHARM)。

Catheterization for Congenital Heart Disease Adjustment for Risk Method (CHARM).

机构信息

Department of Cardiology, The Children's Hospital, Boston, Massachusetts, USA.

出版信息

JACC Cardiovasc Interv. 2011 Sep;4(9):1037-46. doi: 10.1016/j.jcin.2011.05.021.

DOI:10.1016/j.jcin.2011.05.021
PMID:21939947
Abstract

OBJECTIVES

This study sought to develop a method to adjust for case mix complexity in catheterization for congenital heart disease to allow equitable comparisons of adverse event (AE) rates.

BACKGROUND

The C3PO (Congenital Cardiac Catheterization Project on Outcomes) has been prospectively collecting data using a Web-based data entry tool on all catheterization cases at 8 pediatric institutions since 2007.

METHODS

A multivariable logistic regression model with high-severity AE outcome was built using a random sample of 75% of cases in the multicenter cohort; the models were assessed in the remaining 25%. Model discrimination was assessed by the C-statistic and calibration with Hosmer-Lemeshow test. The final models were used to calculate standardized AE ratios.

RESULTS

Between August 2007 and December 2009, 9,362 cases were recorded at 8 pediatric institutions of which high-severity events occurred in 454 cases (5%). Assessment of empirical data yielded 4 independent indicators of hemodynamic vulnerability. Final multivariable models included procedure type risk category (odds ratios [OR] for category: 2 = 2.4, 3 = 4.9, 4 = 7.6, all p < 0.001), number of hemodynamic indicators (OR for 1 indicator = 1.5, ≥2 = 1.8, p = 0.005 and p < 0.001), and age <1 year (OR: 1.3, p = 0.04), C-statistic 0.737, and Hosmer-Lemeshow test p = 0.74. Models performed well in the validation dataset, C-statistic 0.734. Institutional event rates ranged from 1.91% to 7.37% and standardized AE ratios ranged from 0.61 to 1.41.

CONCLUSIONS

Using CHARM (Catheterization for Congenital Heart Disease Adjustment for Risk Method) to adjust for case mix complexity should allow comparisons of AE among institutions performing catheterization for congenital heart disease.

摘要

目的

本研究旨在开发一种用于先天性心脏病导管插入术病例组合复杂性调整的方法,以实现不良事件(AE)发生率的公平比较。

背景

自 2007 年以来,C3PO(先天性心脏导管插入术结局项目)一直使用基于网络的数据输入工具,前瞻性地收集 8 家儿科机构所有导管插入术病例的数据。

方法

使用多中心队列中 75%的病例随机样本构建了一个具有高严重度 AE 结局的多变量逻辑回归模型;在剩余的 25%的病例中评估模型。通过 C 统计量评估模型区分度,并通过 Hosmer-Lemeshow 检验评估校准。使用最终模型计算标准化 AE 比值。

结果

2007 年 8 月至 2009 年 12 月,8 家儿科机构共记录了 9362 例病例,其中 454 例(5%)发生高严重度事件。对经验数据的评估产生了 4 个血流动力学脆弱性的独立指标。最终多变量模型包括手术类型风险类别(类别比值比:2=2.4,3=4.9,4=7.6,均 p<0.001)、血流动力学指标数量(1 个指标=1.5,≥2 个指标=1.8,p=0.005 和 p<0.001)以及年龄<1 岁(比值比:1.3,p=0.04)。C 统计量为 0.737,Hosmer-Lemeshow 检验 p=0.74。模型在验证数据集的表现良好,C 统计量为 0.734。机构事件发生率范围为 1.91%至 7.37%,标准化 AE 比值范围为 0.61 至 1.41。

结论

使用 CHARM(先天性心脏病导管插入术风险调整方法)调整病例组合复杂性,应该可以比较进行先天性心脏病导管插入术的机构之间的 AE。

相似文献

1
Catheterization for Congenital Heart Disease Adjustment for Risk Method (CHARM).先天性心脏病经导管介入治疗风险调整方法(CHARM)。
JACC Cardiovasc Interv. 2011 Sep;4(9):1037-46. doi: 10.1016/j.jcin.2011.05.021.
2
Adverse events rates and risk factors in adults undergoing cardiac catheterization at pediatric hospitals--results from the C3PO.儿科医院行心导管术成人的不良事件发生率和危险因素——C3PO 研究结果。
Catheter Cardiovasc Interv. 2013 May;81(6):997-1005. doi: 10.1002/ccd.24658. Epub 2013 Jan 23.
3
Relationship between procedural adverse events associated with cardiac catheterization for congenital heart disease and operator factors: results of a multi-institutional registry (C3PO).先天性心脏病心导管术相关操作不良事件与术者因素的关系:多中心注册研究(C3PO)结果。
Catheter Cardiovasc Interv. 2013 Sep 1;82(3):463-73. doi: 10.1002/ccd.24866. Epub 2013 Apr 9.
4
Modeling Major Adverse Outcomes of Pediatric and Adult Patients With Congenital Heart Disease Undergoing Cardiac Catheterization: Observations From the NCDR IMPACT Registry (National Cardiovascular Data Registry Improving Pediatric and Adult Congenital Treatment).先天性心脏病患儿及成人患者接受心导管检查的主要不良结局建模:来自NCDR IMPACT注册研究(国家心血管数据注册研究改善小儿及成人先天性心脏病治疗)的观察结果
Circulation. 2017 Nov 21;136(21):2009-2019. doi: 10.1161/CIRCULATIONAHA.117.027714. Epub 2017 Sep 7.
5
Adjusting for Risk Associated With Pediatric and Congenital Cardiac Catheterization: A Report From the NCDR IMPACT Registry.调整与小儿及先天性心脏导管插入术相关的风险:来自国家心血管数据注册机构(NCDR)IMPACT注册库的报告。
Circulation. 2015 Nov 17;132(20):1863-70. doi: 10.1161/CIRCULATIONAHA.114.014694. Epub 2015 Oct 19.
6
Catheterization for Congenital Heart Disease Adjustment for Risk Method II.先天性心脏病的导管插入术 风险调整方法 II.
Circ Cardiovasc Interv. 2024 Mar;17(3):e012834. doi: 10.1161/CIRCINTERVENTIONS.123.012834. Epub 2024 Jan 23.
7
Low weight as an independent risk factor for adverse events during cardiac catheterization of infants.体重低是婴儿心导管检查期间发生不良事件的独立危险因素。
Catheter Cardiovasc Interv. 2013 Nov 1;82(5):786-94. doi: 10.1002/ccd.24726. Epub 2013 Mar 2.
8
A risk adjusted method for comparing adverse outcomes among practitioners in pediatric and congenital cardiac catheterization.一种用于比较儿科和先天性心脏导管插入术中从业者不良结局的风险调整方法。
Congenit Heart Dis. 2008 Jul-Aug;3(4):230-40. doi: 10.1111/j.1747-0803.2008.00196.x.
9
Practice Variation in Single-Ventricle Patients Undergoing Elective Cardiac Catheterization: A Report from the Congenital Cardiac Catheterization Project on Outcomes (C3PO).接受择期心导管插入术的单心室患者的实践差异:先天性心脏病导管插入术结果项目(C3PO)的报告
Congenit Heart Dis. 2016 Mar-Apr;11(2):122-35. doi: 10.1111/chd.12299. Epub 2015 Sep 10.
10
Adverse event rates in congenital cardiac catheterization - a multi-center experience.先天性心脏导管术的不良事件发生率——一项多中心经验。
Catheter Cardiovasc Interv. 2010 Feb 15;75(3):389-400. doi: 10.1002/ccd.22266.

引用本文的文献

1
Programmatic Approach to Outpatient Cardiac Catheterization in Children With Stable Pulmonary Arterial Hypertension.针对患有稳定型肺动脉高压儿童的门诊心脏导管插入术的程序化方法。
Pulm Circ. 2025 Jun 5;15(2):e70105. doi: 10.1002/pul2.70105. eCollection 2025 Apr.
2
[Use of a pediatric risk score for cardiac catheterization in a Spanish population with congenital heart disease].[西班牙先天性心脏病患者群体中用于心脏导管插入术的儿科风险评分的应用]
REC Interv Cardiol. 2023 Aug 9;6(1):20-24. doi: 10.24875/RECIC.M23000399. eCollection 2024 Jan-Mar.
3
Generating Risk Reduction Analytics in Complex Cardiac Care Environments (GRACE): Risk Prediction in Congenital Catheterization.
复杂心脏护理环境中降低风险分析的生成(GRACE):先天性导管插入术的风险预测
J Soc Cardiovasc Angiogr Interv. 2024 Dec 17;4(3Part B):102434. doi: 10.1016/j.jscai.2024.102434. eCollection 2025 Mar.
4
Comparative Congenital Cardiac Catheterization Registry Analysis From the United States and Low- and Middle-Income Countries.美国与低收入和中等收入国家先天性心脏导管插入术登记分析比较
JACC Adv. 2025 Apr;4(4):101649. doi: 10.1016/j.jacadv.2025.101649. Epub 2025 Mar 20.
5
Evaluating Procedural Performance: A Composite Outcome for Atrial Septal Defect and Patent Ductus Arteriosus Closures.评估手术操作表现:房间隔缺损和动脉导管未闭封堵术的综合结局
J Soc Cardiovasc Angiogr Interv. 2025 Jan 9;4(2):102459. doi: 10.1016/j.jscai.2024.102459. eCollection 2025 Feb.
6
Formulation of Quality Improvement Methodology for Risk Mitigation in Congenital Cardiac Catheterization.先天性心脏导管插入术中降低风险的质量改进方法的制定
Pediatr Cardiol. 2025 Jan 14. doi: 10.1007/s00246-024-03738-9.
7
Use of CRISP Modifiers for Adults Undergoing Cardiac Catheterization Procedures: A Single Center Experience.心脏导管插入术成年患者中CRISP修饰符的应用:单中心经验
Pediatr Cardiol. 2024 Dec 19. doi: 10.1007/s00246-024-03728-x.
8
PICS/AEPC/APPCS/CSANZ/SCAI/SOLACI: Expert Consensus Statement on Cardiac Catheterization for Pediatric Patients and Adults With Congenital Heart Disease.PICS/AEPC/APPCS/CSANZ/SCAI/SOLACI:先天性心脏病儿童和成人心脏导管插入术专家共识声明。
J Soc Cardiovasc Angiogr Interv. 2023 Dec 15;3(1):101181. doi: 10.1016/j.jscai.2023.101181. eCollection 2024 Jan.
9
Health Care Disparities in Congenital Cardiology: Considerations Through the Lens of an Interventional Cardiologist.先天性心脏病领域的医疗保健差异:介入心脏病专家视角的思考
J Soc Cardiovasc Angiogr Interv. 2022 Jul 2;1(5):100388. doi: 10.1016/j.jscai.2022.100388. eCollection 2022 Sep-Oct.
10
Evaluating Procedural Performance: A Composite Outcome for Aortic and Pulmonary Valvuloplasty in Congenital Cardiac Catheterization.评估手术操作性能:先天性心脏导管插入术中主动脉和肺动脉瓣成形术的综合结果。
J Soc Cardiovasc Angiogr Interv. 2023 Oct 3;2(6Part A):101119. doi: 10.1016/j.jscai.2023.101119. eCollection 2023 Nov-Dec.